Pramodini Medicare IPO
Price Band
₹110 – ₹118
Issue Size
₹69.04 Cr
Issue Dates
12 Aug – 14 Aug 2026
Listing Date
19 Aug 2026
About Pramodini Medicare Limited
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities. Its service portfolio includes radiology services (MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, interventional radiology), clinical laboratory services (haematology, microbiology, immunology, pathology, biochemistry), and nuclear medicine services (PET-CT, SPECT, nuclear therapy). It operates a 24x7 teleradiology unit and processing laboratory from Vijayawada. As of August 04, 2026, the company operated 16 diagnostic centres across seven states, through four business models: public-private partnership (PPP), private-private partnerships, strategic partnerships with PSUs, and standalone diagnostic centres.
IPO Details
| Price Band | ₹110 – ₹118 |
| Face Value | ₹10 |
| Issue Size | ₹69.04 Cr |
| Fresh Issue | ₹63.14 Cr |
| Offer for Sale | ₹5.9 Cr |
| Total Shares Offered | 58,51,200 |
| Listed On | NSE |
Objects of the Issue
Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres (est. ₹45.15 Cr), and general corporate purposes and unidentified inorganic acquisition.
Key Financial Metrics
EPS (Basic)
₹10.41
P/E Ratio
11.34x
ROE
39.08%
ROCE
34.66%
Debt / Equity
0.34
Financial Performance
| Particulars (₹ Cr) | 31 Mar 2024 | 31 Mar 2025 | 31 Mar 2026 |
|---|---|---|---|
| Revenue | — | — | — |
| EBITDA | 15.53 | 20.97 | 30.9 |
| PAT | 7.14 | 11.14 | 17.38 |
| Total Assets | 48.78 | 56.45 | 93.62 |
| Net Worth | 24.75 | 35.77 | 53.15 |
| Total Borrowings | 11.96 | 10.81 | 17.85 |
Valuation
Market Capitalisation
P/E Ratio
Promoter Holding
Public Holding
Lot Size & Allocation
Investment by Category
| Category | Lot Size | Min Investment | Max Investment |
|---|---|---|---|
| retail | 2 × 1200 | ₹2,83,200 | ₹2,83,200 |
| shni | 3 × 1200 | ₹4,24,800 | ₹9,91,200 |
| bhni | 8 × 1200 | ₹11,32,800 | — |
Reservation / Allocation
| Category | Allocation | Cut-off |
|---|---|---|
| QIB | 45.91% | No |
| NII (HNI) | 17.41% | No |
| Retail | 36.68% | Yes |
| Market Maker | 5.74% | No |
| Anchor Investor (within QIB) | 23.26% | No |
Registrar & Lead Managers
Registrar
Lead Managers (1)
Peer Comparison
| Company | Listed | Mkt Cap (₹ Cr) | EPS (₹) | P/E | ROE % |
|---|---|---|---|---|---|
| Pramodini Medicare IPO (this IPO) | — | 260.14 | ₹10.41 | 11.34x | 39.08% |
| Modern Diagnostic & Research Centre Ltd. | Yes | 36.89 | — | 11.04x | — |
| Invicta Diagnostic Ltd. | Yes | 28.12 | — | 14.51x | — |
| Gaudium IVF & Women Health Ltd. | Yes | 165 | — | 25.36x | — |
Frequently Asked Questions
5 questions about Pramodini Medicare IPO IPO
Important Dates
Community Discussion
Ask questions and share your thoughts about this IPO
Be the first to ask or share about Pramodini Medicare IPO